ENTERA BIO LTD (ENTX) Stock Overview
NASDAQ:ENTX - IL0011429839 - Common Stock
ENTX Key Statistics, Chart & Performance
The current stock price of ENTX is 1.95 USD. In the past month the price increased by 2.09%. In the past year, price increased by 14.04%.
ENTX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.78 | 370.06B | ||
| AMGN | AMGEN INC | 13.56 | 159.03B | ||
| GILD | GILEAD SCIENCES INC | 15.01 | 144.47B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.46 | 102.07B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.11 | 64.58B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.96B | ||
| ARGX | ARGENX SE - ADR | 71.6 | 40.62B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.79 | 33.98B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.63B | ||
| INSM | INSMED INC | N/A | 25.16B | ||
| NTRA | NATERA INC | N/A | 22.11B | ||
| BIIB | BIOGEN INC | 8.69 | 20.39B |
Related stock screener links
About ENTX
Company Profile
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. The firm developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Company Info
ENTERA BIO LTD
Hadassah / Jerusalem Bio, Park, 5th Floor
JERUSALEM 9112002 IL
CEO: Spiros Jamas
Employees: 19
Phone: 97225327151
ENTERA BIO LTD / ENTX FAQ
What is the stock price of ENTERA BIO LTD today?
The current stock price of ENTX is 1.95 USD. The price increased by 2.63% in the last trading session.
What is the ticker symbol for ENTERA BIO LTD stock?
The exchange symbol of ENTERA BIO LTD is ENTX and it is listed on the Nasdaq exchange.
On which exchange is ENTX stock listed?
ENTX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ENTERA BIO LTD stock?
7 analysts have analysed ENTX and the average price target is 10.2 USD. This implies a price increase of 423.08% is expected in the next year compared to the current price of 1.95. Check the ENTERA BIO LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENTERA BIO LTD worth?
ENTERA BIO LTD (ENTX) has a market capitalization of 88.63M USD. This makes ENTX a Micro Cap stock.
How many employees does ENTERA BIO LTD have?
ENTERA BIO LTD (ENTX) currently has 19 employees.
What are the support and resistance levels for ENTERA BIO LTD (ENTX) stock?
ENTERA BIO LTD (ENTX) has a support level at 1.95 and a resistance level at 1.96. Check the full technical report for a detailed analysis of ENTX support and resistance levels.
Is ENTERA BIO LTD (ENTX) expected to grow?
The Revenue of ENTERA BIO LTD (ENTX) is expected to decline by -100% in the next year. Check the estimates tab for more information on the ENTX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ENTERA BIO LTD (ENTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ENTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ENTX, evaluating the profitability, health, valuation and growth aspects
- ENTERA BIO LTD (ENTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENTERA BIO LTD (ENTX) Sales and EPS estimates to see what analysts future expectations are.
- ENTERA BIO LTD (ENTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENTERA BIO LTD (ENTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENTERA BIO LTD (ENTX) Stock Chart to make your own analysis
- ENTERA BIO LTD (ENTX) Latest news and press-releases to stay up to date.
Does ENTERA BIO LTD (ENTX) stock pay dividends?
ENTX does not pay a dividend.
When does ENTERA BIO LTD (ENTX) report earnings?
ENTERA BIO LTD (ENTX) will report earnings on 2025-11-06, after the market close.
What is the Price/Earnings (PE) ratio of ENTERA BIO LTD (ENTX)?
ENTERA BIO LTD (ENTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.14).
What is the Short Interest ratio of ENTERA BIO LTD (ENTX) stock?
The outstanding short interest for ENTERA BIO LTD (ENTX) is 0.16% of its float. Check the ownership tab for more information on the ENTX short interest.
ENTX Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ENTX. When comparing the yearly performance of all stocks, ENTX turns out to be only a medium performer in the overall market: it outperformed 60.39% of all stocks.
ENTX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ENTX. ENTX has a great financial health rating, but its profitability evaluates not so good.
ENTX Financial Highlights
Over the last trailing twelve months ENTX reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS increased by 46.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -46.72% | ||
| ROE | -52.07% | ||
| Debt/Equity | 0 |
ENTX Forecast & Estimates
7 analysts have analysed ENTX and the average price target is 10.2 USD. This implies a price increase of 423.08% is expected in the next year compared to the current price of 1.95.
For the next year, analysts expect an EPS growth of -124.4% and a revenue growth -100% for ENTX